Market Tracker

08/01 9:56am ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

29.19
Real-Time Quote
 -0.08 / -0.27%
Today’s Change
27.51
Today|||52-Week Range
39.95
-0.03%
Year-to-Date

Today’s Trading

Previous close29.27
Today’s open29.27
Day’s range29.18 - 29.56
Volume14,138
Average volume (3 months)599,561
Market cap$1.2B
Dividend yield--
Data as of 9:41am ET, 08/01/2014

Growth & Valuation

Earnings growth (last year)-89.84%
Earnings growth (this year)-1.61%
Earnings growth (next 5 years)+45.00%
Revenue growth (last year)+10.01%
P/E ratio66.8
Price/Sales3.49
Price/Book2.72

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+0.70+1.92%
LCILannett Company Inc+0.64+1.90%
KPTIKaryopharm Therapeut...+0.75+2.16%
RCPTReceptos Inc+0.39+0.94%
Data as of 9:53am ET, 08/01/2014

Financials

Last reporting dateJuly 31, 2014
EPS forecast (this quarter)$0.14
Annual revenue (last year)$336.4M
Annual profit (last year)$16.4M
Net profit margin4.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts